Tuvusertib (M1774) Mechanism of Action: ATR Inhibition in Tumor Cell Research

Tuvusertib (M1774) MOA:Targeting ATR/DNA Damage Response Pathway for Solid Tumor Combination Therapy

🎯 check Tuvusertib (M1774) product page

Tuvusertib (M1774) is a potent, highly selective, ATP-competitive ATR kinase inhibitor. It affects the DNA damage response (DDR) signaling pathway by blocking ATR-mediated Chk1 phosphorylation, effectively inhibiting DNA repair and promoting apoptosis in cancer cells.

Primary Applications and Mechanism of Action